市場調査レポート

商品コード

1317953

嚢胞性線維症市場：薬効分類（気管支拡張薬、CFTR調節薬、粘液溶解薬）、投与経路（吸入薬、経口薬）別-世界予測2023-2030年

Cystic Fibrosis Market by Drug Class (Bronchodilators, CFTR Modulators, Mucolytics), Route of Administration (Inhaled Drugs, Oral Drugs) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

嚢胞性線維症の世界市場は、2023年に58億8,497万米ドル、CAGR 9.51%で大きく成長し、2030年には111億3,034万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の嚢胞性線維症市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.嚢胞性線維症の世界市場規模および予測は？

2.予測期間中、世界の嚢胞性線維症市場を形成するCOVID-19の阻害要因と影響は？

3.嚢胞性線維症の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.嚢胞性線維症の世界市場における競争戦略は？

5.嚢胞性線維症の世界市場における技術動向と規制の枠組みは？

6.嚢胞性線維症の世界市場における主要ベンダーの市場シェアは？

7.嚢胞性線維症の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 嚢胞性線維症の普及率の上昇と診断テクノロジーの向上
  - 嚢胞性線維症の世界の認知度の向上
  - NGO、政府、非公開会社による積極的な取り組み
- 抑制要因
  - 特許切れとジェネリック医薬品
  - 遺伝子変異率の増加
- 機会
  - 研究開発活動と強力な医薬品開発パイプライン
  - 戦略的提携、合併、買収の拡大
- 課題
  - 高額な治療費と複雑な病態生理
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章嚢胞性線維症市場薬物クラス別

気管支拡張薬
CFTR変調器
粘液溶解薬
膵臓酵素サプリメント

第7章嚢胞性線維症市場：投与経路別

吸入薬
経口薬

第8章南北アメリカの嚢胞性線維症市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第9章アジア太平洋地域の嚢胞性線維症市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第10章欧州・中東・アフリカの嚢胞性線維症市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第11章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第12章掲載企業一覧

第13章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. CYSTIC FIBROSIS MARKET RESEARCH PROCESS
FIGURE 2. CYSTIC FIBROSIS MARKET SIZE, 2022 VS 2030
FIGURE 3. CYSTIC FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
FIGURE 5. CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 6. CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 7. CYSTIC FIBROSIS MARKET DYNAMICS
FIGURE 8. CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. CYSTIC FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 15. CYSTIC FIBROSIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. CYSTIC FIBROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CYSTIC FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 5. CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 20. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 32. CHINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. INDIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 50. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 59. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. POLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. CYSTIC FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 99. CYSTIC FIBROSIS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 100. CYSTIC FIBROSIS MARKET LICENSE & PRICING

Product Code: MRR-4316E4E8958B

The Global Cystic Fibrosis Market is forecasted to grow significantly, with a projected USD 5,884.97 million in 2023 at a CAGR of 9.51% and expected to reach a staggering USD 11,130.34 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cystic Fibrosis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cystic Fibrosis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across Bronchodilators, CFTR Modulators, Mucolytics, and Pancreatic Enzyme Supplements. The CFTR Modulators is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Inhaled Drugs and Oral Drugs. The Inhaled Drugs is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cystic Fibrosis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cystic Fibrosis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cystic Fibrosis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cystic Fibrosis Market?

4. What is the competitive strategic window for opportunities in the Global Cystic Fibrosis Market?

5. What are the technology trends and regulatory frameworks in the Global Cystic Fibrosis Market?

6. What is the market share of the leading vendors in the Global Cystic Fibrosis Market?

7. What modes and strategic moves are considered suitable for entering the Global Cystic Fibrosis Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cystic Fibrosis Market, by Drug Class, 2022 vs 2030
4.3. Cystic Fibrosis Market, by Route of Administration, 2022 vs 2030
4.4. Cystic Fibrosis Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of Cystic Fibrosis & improved diagnostic technologies
  - 5.1.1.2. Increasing global awareness for Cystic Fibrosis
  - 5.1.1.3. Favorable initiatives are taken by NGOs, government, and private companies
- 5.1.2. Restraints
  - 5.1.2.1. Expiring patents and generic drugs
  - 5.1.2.2. Increase in genetic mutation rate
- 5.1.3. Opportunities
  - 5.1.3.1. Research & development activities and robust drug development pipeline
  - 5.1.3.2. Growing strategic collaborations, merger, and acquisition
- 5.1.4. Challenges
  - 5.1.4.1. High cost involved in treatment and complicated pathophysiology
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Cystic Fibrosis Market, by Drug Class

6.1. Introduction
6.2. Bronchodilators
6.3. CFTR Modulators
6.4. Mucolytics
6.5. Pancreatic Enzyme Supplements

7. Cystic Fibrosis Market, by Route of Administration

7.1. Introduction
7.2. Inhaled Drugs
7.3. Oral Drugs

8. Americas Cystic Fibrosis Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cystic Fibrosis Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cystic Fibrosis Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

嚢胞性線維症市場：薬効分類（気管支拡張薬、CFTR調節薬、粘液溶解薬）、投与経路（吸入薬、経口薬）別-世界予測2023-2030年

Cystic Fibrosis Market by Drug Class (Bronchodilators, CFTR Modulators, Mucolytics), Route of Administration (Inhaled Drugs, Oral Drugs) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章嚢胞性線維症市場薬物クラス別

第7章嚢胞性線維症市場：投与経路別

第8章南北アメリカの嚢胞性線維症市場

第9章アジア太平洋地域の嚢胞性線維症市場

第10章欧州・中東・アフリカの嚢胞性線維症市場

第11章競合情勢

第12章掲載企業一覧

第13章付録

LIST OF FIGURES

LIST OF TABLES

Market Segmentation & Coverage:

This research report categorizes the Global Cystic Fibrosis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Cystic Fibrosis Market, by Drug Class

7. Cystic Fibrosis Market, by Route of Administration

8. Americas Cystic Fibrosis Market

9. Asia-Pacific Cystic Fibrosis Market

10. Europe, Middle East & Africa Cystic Fibrosis Market

11. Competitive Landscape

12. List of Company Mentioned

13. Appendix

嚢胞性線維症市場：薬効分類（気管支拡張薬、CFTR調節薬、粘液溶解薬）、投与経路（吸入薬、経口薬）別-世界予測2023-2030年

Cystic Fibrosis Market by Drug Class (Bronchodilators, CFTR Modulators, Mucolytics), Route of Administration (Inhaled Drugs, Oral Drugs) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 嚢胞性線維症市場薬物クラス別

第7章 嚢胞性線維症市場：投与経路別

第8章 南北アメリカの嚢胞性線維症市場

第9章 アジア太平洋地域の嚢胞性線維症市場

第10章 欧州・中東・アフリカの嚢胞性線維症市場

第11章 競合情勢

第12章 掲載企業一覧

第13章 付録

LIST OF FIGURES

LIST OF TABLES

Market Segmentation & Coverage:

This research report categorizes the Global Cystic Fibrosis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Cystic Fibrosis Market, by Drug Class

7. Cystic Fibrosis Market, by Route of Administration

8. Americas Cystic Fibrosis Market

9. Asia-Pacific Cystic Fibrosis Market

10. Europe, Middle East & Africa Cystic Fibrosis Market

11. Competitive Landscape

12. List of Company Mentioned

13. Appendix

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章嚢胞性線維症市場薬物クラス別

第7章嚢胞性線維症市場：投与経路別

第8章南北アメリカの嚢胞性線維症市場

第9章アジア太平洋地域の嚢胞性線維症市場

第10章欧州・中東・アフリカの嚢胞性線維症市場

第11章競合情勢

第12章掲載企業一覧

第13章付録